These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31837559)

  • 1. Rivaroxaban in patients with mechanical heart valves: A pilot study.
    Roost E; Weber A; Alberio L; Englberger L; Reineke D; Keller D; Nagler M; Carrel T
    Thromb Res; 2020 Feb; 186():1-6. PubMed ID: 31837559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
    Kumar V; Kelly S; Raizada A; Yee J; Anuwatworn A; Stys A; Stys M
    Methodist Debakey Cardiovasc J; 2017; 13(2):73-75. PubMed ID: 28740586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model.
    Greiten LE; McKellar SH; Rysavy J; Schaff HV
    Eur J Cardiothorac Surg; 2014 May; 45(5):914-9. PubMed ID: 24306948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early failure of a bioprosthetic aortic valve due to thrombus formation while on rivaroxaban.
    Leatherby RJ; Osman M; Birdi I; Serino W
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1231-1233. PubMed ID: 30445492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical Prosthetic Heart Valve Thrombosis in a Patient Receiving Rivaroxaban.
    Carvalho Silva DM; Braga A; de Jesus I; Neves J
    Cardiology; 2019; 143(3-4):116-120. PubMed ID: 31473736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin Generation.
    Jaffer IH; Fredenburgh JC; Stafford A; Whitlock RP; Weitz JI
    Ann Thorac Surg; 2020 Aug; 110(2):582-590. PubMed ID: 31877292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    De Backer O; Dangas GD; Jilaihawi H; Leipsic JA; Terkelsen CJ; Makkar R; Kini AS; Veien KT; Abdel-Wahab M; Kim WK; Balan P; Van Mieghem N; Mathiassen ON; Jeger RV; Arnold M; Mehran R; Guimarães AHC; Nørgaard BL; Kofoed KF; Blanke P; Windecker S; Søndergaard L;
    N Engl J Med; 2020 Jan; 382(2):130-139. PubMed ID: 31733182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Coagulation Changes With or Without Direct Oral Anticoagulant Therapy Following Transcatheter Aortic Valve Implantation.
    Katayama T; Yokoyama N; Watanabe Y; Takahashi S; Hioki H; Kawasugi K; Kozuma K
    Am J Cardiol; 2021 May; 147():88-93. PubMed ID: 33617810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Windecker S; Tijssen J; Giustino G; Guimarães AH; Mehran R; Valgimigli M; Vranckx P; Welsh RC; Baber U; van Es GA; Wildgoose P; Volkl AA; Zazula A; Thomitzek K; Hemmrich M; Dangas GD
    Am Heart J; 2017 Feb; 184():81-87. PubMed ID: 27892890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis.
    Durães AR; Bitar YSL; Lima MLG; Santos CC; Schonhofen IS; Filho JAL; Roever L
    Am J Cardiol; 2018 Sep; 122(6):1047-1050. PubMed ID: 30098707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    Dangas GD; Tijssen JGP; Wöhrle J; Søndergaard L; Gilard M; Möllmann H; Makkar RR; Herrmann HC; Giustino G; Baldus S; De Backer O; Guimarães AHC; Gullestad L; Kini A; von Lewinski D; Mack M; Moreno R; Schäfer U; Seeger J; Tchétché D; Thomitzek K; Valgimigli M; Vranckx P; Welsh RC; Wildgoose P; Volkl AA; Zazula A; van Amsterdam RGM; Mehran R; Windecker S;
    N Engl J Med; 2020 Jan; 382(2):120-129. PubMed ID: 31733180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model.
    Lester PA; Coleman DM; Diaz JA; Jackson TO; Hawley AE; Mathues AR; Grant BT; Knabb RM; Ramacciotti E; Frost CE; Song Y; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):942-948. PubMed ID: 28232327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.
    Kaeberich A; Reindl I; Raaz U; Maegdefessel L; Vogt A; Linde T; Steinseifer U; Perzborn E; Hauroeder B; Buerke M; Werdan K; Schlitt A
    J Thromb Thrombolysis; 2011 Nov; 32(4):417-25. PubMed ID: 21773837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.
    Wypasek E; Natorska J; Mazur P; Kopytek M; Gawęda B; Kapusta P; Madeja J; Iwaniec T; Kapelak B; Undas A
    Vascul Pharmacol; 2020 Jul; 130():106679. PubMed ID: 32387621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Very Early Thrombosis of SAPIEN 3 Valve with Direct Oral Anticoagulant Therapy.
    Ruparelia N; Panoulas VF; Frame A; Sutaria N; Ariff B; Gopalan D; Chukwuemeka A; Mikhail GW; Malik IS
    J Heart Valve Dis; 2016 Mar; 25(2):211-213. PubMed ID: 27989069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Therapeutic Morass.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Imran M; Papanikolaou D; Erben Y; Zefirova J; Ziganshin BA; Elefteriades JA
    Cardiology; 2018; 140(4):213-221. PubMed ID: 30138919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
    Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal aortic flow profiles persist after aortic valve replacement in the majority of patients with aortic valve disease: how model-based personalized therapy planning could improve results. A pilot study approach.
    Nordmeyer S; Hellmeier F; Yevtushenko P; Kelm M; Lee CB; Lehmann D; Kropf S; Berger F; Falk V; Knosalla C; Kuehne T; Goubergrits L
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):133-141. PubMed ID: 31131388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Obstructive Transcatheter Heart Valve Thrombosis Resolved by Rivaroxaban.
    Mathiassen ON; Grove EL; Hansson NC; Norgaard BL
    Am J Case Rep; 2017 May; 18():573-575. PubMed ID: 28536415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.